BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22961777)

  • 1. Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort.
    Dhillon PK; Kenfield SA; Stampfer MJ; Giovannucci EL; Chan JM
    Cancer Prev Res (Phila); 2012 Oct; 5(10):1223-8. PubMed ID: 22961777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.
    Downer MK; Allard CB; Preston MA; Wilson KM; Kenfield SA; Chan JM; Mucci LA; Giovannucci E; Stampfer MJ
    Eur Urol Oncol; 2019 Mar; 2(2):126-134. PubMed ID: 31017087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
    Downer MK; Allard CB; Preston MA; Gaziano JM; Stampfer MJ; Mucci LA; Batista JL
    Eur Urol; 2017 Nov; 72(5):821-827. PubMed ID: 28189429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study.
    Hurwitz LM; Joshu CE; Barber JR; Prizment AE; Vitolins MZ; Jones MR; Folsom AR; Han M; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):563-569. PubMed ID: 30487131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
    Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Dalton SO; Nørgaard M; Pottegård A; Hallas J; Sørensen HT; Friis S
    Ann Intern Med; 2019 Apr; 170(7):443-452. PubMed ID: 30831581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006.
    Dhillon PK; Kenfield SA; Stampfer MJ; Giovannucci EL
    Int J Cancer; 2011 May; 128(10):2444-52. PubMed ID: 21128233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up Study.
    Barry M; Dhillon PK; Stampfer MJ; Perner S; Ma J; Giovannucci E; Kurth T; Mucci LA; Rubin MA
    Prostate; 2012 Feb; 72(3):301-6. PubMed ID: 21713964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
    Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
    J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.
    Veitonmäki T; Tammela TL; Auvinen A; Murtola TJ
    Eur J Cancer; 2013 Mar; 49(4):938-45. PubMed ID: 23079475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
    Zhou CK; Daugherty SE; Liao LM; Freedman ND; Abnet CC; Pfeiffer R; Cook MB
    Cancer Prev Res (Phila); 2017 Jul; 10(7):410-420. PubMed ID: 28507039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postdiagnostic Statin Use and the Risk of Lethal Prostate Cancer in the Health Professionals Follow-up Study.
    Chan JM; Kenfield SA; Paciorek A; Platz EA; Giovannucci EL; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1638-40. PubMed ID: 26189767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer.
    Preston MA; Wilson KM; Markt SC; Ge R; Morash C; Stampfer MJ; Loda M; Giovannucci E; Mucci LA; Olumi AF
    JAMA Intern Med; 2014 Aug; 174(8):1301-7. PubMed ID: 24887392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
    Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
    Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
    J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study.
    Downer MK; Kenfield SA; Stampfer MJ; Wilson KM; Dickerman BA; Giovannucci EL; Rimm EB; Wang M; Mucci LA; Willett WC; Chan JM; Van Blarigan EL
    J Clin Oncol; 2019 Jun; 37(17):1499-1511. PubMed ID: 31026211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prospective Study of Aspirin Use and Prostate Cancer Risk by
    Stopsack KH; Gonzalez-Feliciano AG; Peisch SF; Downer MK; Gage RA; Finn S; Lis RT; Graff RE; Pettersson A; Pernar CH; Loda M; Kantoff PW; Ahearn TU; Mucci LA;
    Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1231-1233. PubMed ID: 30108097
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
    Veitonmäki T; Murtola TJ; Talala K; Taari K; Tammela T; Auvinen A
    PLoS One; 2016; 11(4):e0153413. PubMed ID: 27100876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume.
    Fowke JH; Motley SS; Smith JA; Cookson MS; Concepcion R; Chang SS; Byerly S
    J Urol; 2009 May; 181(5):2064-70. PubMed ID: 19286210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.
    Sarkar RR; Parsons JK; Bryant AK; Ryan ST; Kader AK; McKay RR; D'Amico AV; Nguyen PL; Hulley BJ; Einck JP; Mundt AJ; Kane CJ; Murphy JD; Rose BS
    JAMA Intern Med; 2019 Jun; 179(6):812-819. PubMed ID: 31058923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.